Literature DB >> 2892872

Risk of anaphylaxis in patients receiving beta-blocker drugs.

J H Toogood1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2892872     DOI: 10.1016/0091-6749(88)90212-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  21 in total

1.  Sexual harassment at work.

Authors:  P Forster
Journal:  BMJ       Date:  1992-10-17

Review 2.  Anaphylactic and anaphylactoid reactions. Clinical presentation.

Authors:  D A Moneret-Vautrin; M C Laxenaire
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

Review 3.  Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?

Authors:  David M Lang
Journal:  Curr Allergy Asthma Rep       Date:  2008-03       Impact factor: 4.806

Review 4.  Therapeutic controversies in the management of acute anaphylaxis.

Authors:  A F Brown
Journal:  J Accid Emerg Med       Date:  1998-03

5.  Comparative effects of dilevalol and atenolol on lung function and airway response to methacholine in hypertensive subjects.

Authors:  L P Boulet; Y Lacourcière; J Milot; N Lampron
Journal:  Br J Clin Pharmacol       Date:  1990-06       Impact factor: 4.335

Review 6.  Perioperative anaphylaxis.

Authors:  Violeta Régnier Galvão; Pedro Giavina-Bianchi; Mariana Castells
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

Review 7.  Anaphylactic shock: mechanisms and treatment.

Authors:  A F Brown
Journal:  J Accid Emerg Med       Date:  1995-06

Review 8.  Diagnosis of drug allergic reactions.

Authors:  D Vervloet; M Pradal; D Charpin; F Porri
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

9.  Prospective audit of adverse reactions occurring in 459 primary antibody-deficient patients receiving intravenous immunoglobulin.

Authors:  V M Brennan; N J Salomé-Bentley; H M Chapel
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

10.  Navigating the updated anaphylaxis parameters.

Authors:  Stephen F Kemp
Journal:  Allergy Asthma Clin Immunol       Date:  2007-06-15       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.